Clinical trials recruiting for Oligometastatic Prostate Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Abiraterone acetate | 1 |
| Antiandrogen Therapy | 1 |
| Gonadotropin-releasing Hormone Analog | 1 |
| Hypofractionated Radiation Therapy | 1 |
| Stereotactic Body Radiation Therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 2 |
| Florida | 1 |
| Georgia | 1 |
| Minnesota | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
- Addressing Health Literacy With a Tailored Survivorship Care Plan
- OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate
- Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
- SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Related conditions
Trials recruiting for Oligometastatic Prostate Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Oligometastatic Prostate Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.